牛牛AI助手已提取核心信息
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired on 02/17/2024 as part of compensation in the form of performance shares and restricted stock vesting, both from the issuer. This transaction follows a previous sale of 3,145 shares within the past three months, which had gross proceeds of $1,316,305.52. The planned sale is in accordance with a trading plan adopted on 08/25/2023.
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 4,002 shares of common stock on 02/20/2024, with an aggregate market value of approximately $1,684,001.58. The shares to be sold were recently acquired on 02/17/2024 as part of compensation in the form of performance shares and restricted stock vesting, both from the issuer. This transaction follows a previous sale of 3,145 shares within the past three months, which had gross proceeds of $1,316,305.52. The planned sale is in accordance with a trading plan adopted on 08/25/2023.
Vertex Pharmicals Inc.高管巴斯蒂亚诺·桑纳定于2024年2月20日出售4,002股普通股，总市值约为1,684,001.58美元。拟出售的股票最近于2024年2月17日以绩效股和限制性股票归属的形式从发行人手中收购，作为补偿的一部分。该交易是在过去三个月内出售3,145股股票之后进行的，总收益为1,316,305.52美元。计划中的出售符合2023年8月25日通过的交易计划。
Vertex Pharmicals Inc.高管巴斯蒂亚诺·桑纳定于2024年2月20日出售4,002股普通股，总市值约为1,684,001.58美元。拟出售的股票最近于2024年2月17日以绩效股和限制性股票归属的形式从发行人手中收购，作为补偿的一部分。该交易是在过去三个月内出售3,145股股票之后进行的，总收益为1,316,305.52美元。计划中的出售符合2023年8月25日通过的交易计划。
有用
没用
该公告为独立文件：